USA: +1 347 690-0211 | UK: +44 2032 894158 | Translate :

Search Market Research Report

Discover Our Latest Reports

Discover Our Featured Reports

Discover Top Selling Reports

MicroRNA Market Size, Share Global Analysis Report, 2023 – 2030

Name: MicroRNA Market Size, Share, Growth Analysis Report By Application(Clinical Diagnostics and Research) and By End Use(Research and Academic Institutes, Contract Research Organizations, Biopharmaceutical Companies, and Diagnostic Centers), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2023 – 2030
Creator: Facts and Factors
License: https://www.fnfresearch.com/privacy-policy

MicroRNA Market Size, Share, Growth Analysis Report By Application(Clinical Diagnostics and Research) and By End Use(Research and Academic Institutes, Contract Research Organizations, Biopharmaceutical Companies, and Diagnostic Centers), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2023 – 2030

Industry Insights

[180+ Pages Report] According to the report published by Facts Factors, the global microRNA market size was worth around USD 1,240 million in 2022 and is predicted to grow to around USD 3,960 million by 2030 with a compound annual growth rate (CAGR) of roughly 18.04% between 2023 and 2030. The report analyzes the global microRNA market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the microRNA market.

MicroRNA Market

To know more about this report | Request Free Sample Copy

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the MicroRNA industry. The report analyzes and declares the historical and current trends analysis of the MicroRNA industry and subsequently recommends the projected trends anticipated to be observed in the MicroRNA market during the upcoming years.

The MicroRNA market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entireMicroRNA market. The historical and past insights are provided for FY 2020 to FY 2022 whereas projected trends are delivered for FY 2023 to FY 2030. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2020 – 2030.

Key Insights from Primary Research

As per our analysis, the MicroRNA market is set to grow annually at a rate of around 18.04%
It was valued through primaryresearch that the MicroRNAmarket was valued at around USD 1,240 Million in 2022
North Americais currently holding the largestshare among all the regions and expected to continue the trend in the upcoming period.
Rapid progress is expected to foster Asia Pacific growth in genomic studies and increasing use of advanced technologies.

Key Recommendations from Analysts

As per our analysisit was anticipated that during the forecast period application of the market will grow majorly in developed countries
The market value for year 2030 was estimated USD 3,960 Million
Asia-Pacific region is likely to witness fastest growth during the analysis period
As per our analysts, recent innovations and increasing applications are expected to contribute over the forecast period to market growth forMicroRNA.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the MicroRNA industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the MicroRNA industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the MicroRNA market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the MicroRNA industry. The MicroRNA market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the MicroRNAsector. Key strategic developments in the MicroRNA market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the MicroRNA market are appropriately highlighted in the report.

The move from platform technology to applications is expected to fuel the market. The development of drugs and biologics across virtual drug development systems provides significant advantages over traditional models, such as reducing risk and overhead costs in combination with conventional technologies. MirNAs play a significant role in various biological processes, such as time-control development, cell proliferation, apoptosis, stem cell maintenance, differentiation, signal pathways, and pathogenesis, such as carcinogenesis. During the forecast period, this factor is expected to increase the market growth.

The MicroRNA market research report delivers an acutevaluationand taxonomy of the MicroRNA industry by practically splitting the market on the basis of different applications, end-use, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026.

Report Scope

Report Attribute	Details
Market Size in 2022	USD 1,240 Million
Projected Market Size in 2030	USD 3,960 Million
CAGR Growth Rate	18.04% CAGR
Base Year	2022
Forecast Years	2023-2030
Key Market Players	Affymetrix, Alnylam Pharmaceuticals Inc.,AstraZeneca Pharmaceuticals LP, Santaris Pharma, Biogen Idec Inc., Exiqon, Pfizer Inc., CBC Biomarker Center GmbH, Eli Lilly and Co., F. Hoffman-La Roche, GlaxoSmithKline, Novartis AG, and Merck & Co., and Others
Key Segment	By Application, End-Use, and Region
Major Regions Covered	North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
Purchase Options	Request customized purchase options to meet your research needs.Explore purchase options

The regional segmentation of the MicroRNA industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Further, country-wise data for the MicroRNA industry is provided for the leading economies of the world.

The MicroRNA market is segmented based on application and end-use. On the basis of application segmentation, the market is classified into clinical diagnostics and research. In terms of end-use segmentation, the market is bifurcated into research and academic institutes, contract research organizations, biopharmaceutical companies, and diagnostic centers.

Some of the major players operating in the MicroRNA market

Affymetrix
Alnylam Pharmaceuticals Inc.
AstraZeneca Pharmaceuticals LP
Santaris Pharma
Biogen Idec Inc.
Exiqon
Pfizer Inc.
CBC Biomarker Center GmbH
Eli Lilly and Co.
F. Hoffman-La Roche
GlaxoSmithKline
Novartis AG and Merck & Co.

The taxonomy of the MicroRNA industry by its scope and segmentation is as follows:

By ApplicationSegmentation Analysis

Clinical Diagnostics
Research

By End-Use Segmentation Analysis

Research and Academic Institutes
Contract Research Organizations
Biopharmaceutical Companies
Diagnostic Centres

By Regional Segmentation Analysis

North America
- The U.S.
- Canada
Europe
- Germany
- The UK
- France
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa

Table of Content

CHAPTER 1. Executive Summary
CHAPTER 2. MicroRNA market – Application Analysis
1. 2.1. Global MicroRNA Market – Application Overview
2. 2.2. Global MicroRNA Market Share, by Application, 2022 & 2030 (USD Million)
3. 2.3. Clinical Diagnostics
  1. 2.3.1. Global Clinical Diagnostics MicroRNA Market, 2020-2022 (USD Million)
4. 2.4. Research
  1. 2.4.1. Global Research MicroRNA Market, 2020-2022 (USD Million)
CHAPTER 3. MicroRNA market – End Use Analysis
1. 3.1. Global MicroRNA Market – End Use Overview
2. 3.2. Global MicroRNA Market Share, by End Use, 2022 & 2030 (USD Million)
3. 3.3. Research and Academic Institutes
  1. 3.3.1. Global Research and Academic Institutes MicroRNA Market, 2020-2022 (USD Million)
4. 3.4. Contract Research Organizations
  1. 3.4.1. Global Contract Research Organizations MicroRNA Market, 2020-2022 (USD Million)
5. 3.5. Biopharmaceutical Companies
  1. 3.5.1. Global Biopharmaceutical Companies MicroRNA Market, 2020-2022 (USD Million)
6. 3.6. Diagnostic Centers
  1. 3.6.1. Global Diagnostic Centers MicroRNA Market, 2020-2022 (USD Million)
CHAPTER 4. MicroRNA market – Regional Analysis
1. 4.1. Global MicroRNA Market Regional Overview
2. 4.2. Global MicroRNA Market Share, by Region, 2022 & 2030 (Value)
3. 4.3. North America
  1. 4.3.1. North America MicroRNA Market size and forecast, 2020-2022
  2. 4.3.2. North America MicroRNA Market, by Country, 2022 & 2030 (USD Million)
  3. 4.3.3. North America MicroRNA Market, by Application, 2020-2022
    1. 4.3.3.1. North America MicroRNA Market, by Application, 2020-2022 (USD Million)
  4. 4.3.4. North America MicroRNA Market, by End Use, 2020-2022
    1. 4.3.4.1. North America MicroRNA Market, by End Use, 2020-2022 (USD Million)
  5. 4.3.5. U.S.
    1. 4.3.5.1. U.S. Market size and forecast, 2020-2022 (USD Million)
  6. 4.3.6. Canada
    1. 4.3.6.1. Canada Market size and forecast, 2020-2022 (USD Million)
4. 4.4. Europe
  1. 4.4.1. Europe MicroRNA Market size and forecast, 2020-2022
  2. 4.4.2. Europe MicroRNA Market, by Country, 2022 & 2030 (USD Million)
  3. 4.4.3. Europe MicroRNA Market, by Application, 2020-2022
    1. 4.4.3.1. Europe MicroRNA Market, by Application, 2020-2022 (USD Million)
  4. 4.4.4. Europe MicroRNA Market, by End Use, 2020-2022
    1. 4.4.4.1. Europe MicroRNA Market, by End Use, 2020-2022 (USD Million)
  5. 4.4.5. Germany
    1. 4.4.5.1. Germany Market size and forecast, 2020-2022 (USD Million)
  6. 4.4.6. France
    1. 4.4.6.1. France Market size and forecast, 2020-2022 (USD Million)
  7. 4.4.7. U.K.
    1. 4.4.7.1. U.K. Market size and forecast, 2020-2022 (USD Million)
  8. 4.4.8. Italy
    1. 4.4.8.1. Italy Market size and forecast, 2020-2022 (USD Million)
  9. 4.4.9. Spain
    1. 4.4.9.1. Spain Market size and forecast, 2020-2022 (USD Million)
  10. 4.4.10. Rest of Europe
    1. 4.4.10.1. Rest of Europe Market size and forecast, 2020-2022 (USD Million)
5. 4.5. Asia Pacific
  1. 4.5.1. Asia Pacific MicroRNA Market size and forecast, 2020-2022
  2. 4.5.2. Asia Pacific MicroRNA Market, by Country, 2022 & 2030 (USD Million)
  3. 4.5.3. Asia Pacific MicroRNA Market, by Application, 2020-2022
    1. 4.5.3.1. Asia Pacific MicroRNA Market, by Application, 2020-2022 (USD Million)
  4. 4.5.4. Asia Pacific MicroRNA Market, by End Use, 2020-2022
    1. 4.5.4.1. Asia Pacific MicroRNA Market, by End Use, 2020-2022 (USD Million)
  5. 4.5.5. China
    1. 4.5.5.1. China Market size and forecast, 2020-2022 (USD Million)
  6. 4.5.6. Japan
    1. 4.5.6.1. Japan Market size and forecast, 2020-2022 (USD Million)
  7. 4.5.7. India
    1. 4.5.7.1. India Market size and forecast, 2020-2022 (USD Million)
  8. 4.5.8. South Korea
    1. 4.5.8.1. South Korea Market size and forecast, 2020-2022 (USD Million)
  9. 4.5.9. South-East Asia
    1. 4.5.9.1. South-East Asia Market size and forecast, 2020-2022 (USD Million)
  10. 4.5.10. Rest of Asia Pacific
    1. 4.5.10.1. Rest of Asia Pacific Market size and forecast, 2020-2022 (USD Million)
6. 4.6. Latin America
  1. 4.6.1. Latin America MicroRNA Market size and forecast, 2020-2022
  2. 4.6.2. Latin America MicroRNA Market, by Country, 2022 & 2030 (USD Million)
  3. 4.6.3. Latin America MicroRNA Market, by Application, 2020-2022
    1. 4.6.3.1. Latin America MicroRNA Market, by Application, 2020-2022 (USD Million)
  4. 4.6.4. Latin America MicroRNA Market, by End Use, 2020-2022
    1. 4.6.4.1. Latin America MicroRNA Market, by End Use, 2020-2022 (USD Million)
  5. 4.6.5. Brazil
    1. 4.6.5.1. Brazil Market size and forecast, 2020-2022 (USD Million)
  6. 4.6.6. Mexico
    1. 4.6.6.1. Mexico Market size and forecast, 2020-2022 (USD Million)
  7. 4.6.7. Rest of Latin America
    1. 4.6.7.1. Rest of Latin America Market size and forecast, 2020-2022 (USD Million)
7. 4.7. The Middle-East and Africa
  1. 4.7.1. The Middle-East and Africa MicroRNA Market size and forecast, 2020-2022
  2. 4.7.2. The Middle-East and Africa MicroRNA Market, by Country, 2022 & 2030 (USD Million)
  3. 4.7.3. The Middle-East and Africa MicroRNA Market, by Application, 2020-2022
    1. 4.7.3.1. The Middle-East and Africa MicroRNA Market, by Application, 2020-2022 (USD Million)
  4. 4.7.4. The Middle-East and Africa MicroRNA Market, by End Use, 2020-2022
    1. 4.7.4.1. The Middle-East and Africa MicroRNA Market, by End Use, 2020-2022 (USD Million)
  5. 4.7.5. GCC Countries
    1. 4.7.5.1. GCC Countries Market size and forecast, 2020-2022 (USD Million)
  6. 4.7.6. South Africa
    1. 4.7.6.1. South Africa Market size and forecast, 2020-2022 (USD Million)
  7. 4.7.7. Rest of Middle-East Africa
    1. 4.7.7.1. Rest of Middle-East Africa Market size and forecast, 2020-2022 (USD Million)
CHAPTER 5. MicroRNA market – Competitive Landscape
1. 5.1. Competitor Market Share – Revenue
2. 5.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
3. 5.3. Strategic Development
  1. 5.3.1. Acquisitions and Mergers
  2. 5.3.2. New Products
  3. 5.3.3. Research & Development Activities
CHAPTER 6. Company Profiles
1. 6.1. Affymetrix
  1. 6.1.1. Company Overview
  2. 6.1.2. Affymetrix Revenue and Gross Margin
  3. 6.1.3. Product portfolio
  4. 6.1.4. Recent initiatives
2. 6.2. Alnylam Pharmaceuticals Inc.
  1. 6.2.1. Company Overview
  2. 6.2.2. Alnylam Pharmaceuticals Inc. Revenue and Gross Margin
  3. 6.2.3. Product portfolio
  4. 6.2.4. Recent initiatives
3. 6.3. AstraZeneca Pharmaceuticals LP
  1. 6.3.1. Company Overview
  2. 6.3.2. AstraZeneca Pharmaceuticals LP Revenue and Gross Margin
  3. 6.3.3. Product portfolio
  4. 6.3.4. Recent initiatives
4. 6.4. Santaris Pharma
  1. 6.4.1. Company Overview
  2. 6.4.2. Santaris Pharma Revenue and Gross Margin
  3. 6.4.3. Product portfolio
  4. 6.4.4. Recent initiatives
5. 6.5. Biogen Idec Inc.
  1. 6.5.1. Company Overview
  2. 6.5.2. Biogen Idec Inc. Revenue and Gross Margin
  3. 6.5.3. Product portfolio
  4. 6.5.4. Recent initiatives
6. 6.6. Exiqon
  1. 6.6.1. Company Overview
  2. 6.6.2. Exiqon Revenue and Gross Margin
  3. 6.6.3. Product portfolio
  4. 6.6.4. Recent initiatives
7. 6.7. Pfizer Inc.
  1. 6.7.1. Company Overview
  2. 6.7.2. Pfizer Inc. Revenue and Gross Margin
  3. 6.7.3. Product portfolio
  4. 6.7.4. Recent initiatives
8. 6.8. CBC Biomarker Center GmbH
  1. 6.8.1. Company Overview
  2. 6.8.2. CBC Biomarker Center GmbH Revenue and Gross Margin
  3. 6.8.3. Product portfolio
  4. 6.8.4. Recent initiatives
9. 6.9. Eli Lilly and Co.
  1. 6.9.1. Company Overview
  2. 6.9.2. Eli Lilly and Co. Revenue and Gross Margin
  3. 6.9.3. Product portfolio
  4. 6.9.4. Recent initiatives
10. 6.10. F. Hoffman-La Roche
  1. 6.10.1. Company Overview
  2. 6.10.2. F. Hoffman-La Roche Revenue and Gross Margin
  3. 6.10.3. Product portfolio
  4. 6.10.4. Recent initiatives
11. 6.11. GlaxoSmithKline
  1. 6.11.1. Company Overview
  2. 6.11.2. GlaxoSmithKline Revenue and Gross Margin
  3. 6.11.3. Product portfolio
  4. 6.11.4. Recent initiatives
12. 6.12. Novartis AG and Merck & Co.
  1. 6.12.1. Company Overview
  2. 6.12.2. Novartis AG and Merck & Co. Revenue and Gross Margin
  3. 6.12.3. Product portfolio
  4. 6.12.4. Recent initiatives
CHAPTER 7. MicroRNA — Industry Analysis
1. 7.1. MicroRNA Market – Key Trends
  1. 7.1.1. Market Drivers
  2. 7.1.2. Market Restraints
  3. 7.1.3. Market Opportunities
2. 7.2. Value Chain Analysis
3. 7.3. Technology Roadmap and Timeline
4. 7.4. MicroRNA Market – Attractiveness Analysis
  1. 7.4.1. By Application
  2. 7.4.2. By End Use
  3. 7.4.3. By Region
CHAPTER 8. Marketing Strategy Analysis, Distributors
1. 8.1. Marketing Channel
2. 8.2. Direct Marketing
3. 8.3. Indirect Marketing
4. 8.4. Marketing Channel Development Trend
5. 8.5. Economic/Political Environmental Change
CHAPTER 9. Report Conclusion

CHAPTER 10. Research Approach & Methodology

10.1. Report Description
10.2. Research Scope

10.3. Research Methodology

10.3.1. Secondary Research
10.3.2. Primary Research

10.3.3. Models

10.3.3.1. Company Share Analysis Model
10.3.3.2. Revenue Based Modeling
10.3.3.3. Research Limitations

List of Figures

FIG. 1 Global MicroRNA Market, 2020-2022 (USD Million)
FIG. 2 Global MicroRNA Market Share, by Application, 2022 & 2030 (USD Million)
FIG. 3 Global Clinical Diagnostics MicroRNA Market, 2020-2022 (USD Million)
FIG. 4 Global Research MicroRNA Market, 2020-2022 (USD Million)
FIG. 5 Global MicroRNA Market Share, by End Use, 2022 & 2030 (USD Million)
FIG. 6 Global Research and Academic Institutes MicroRNA Market, 2020-2022 (USD Million)
FIG. 7 Global Contract Research Organizations MicroRNA Market, 2020-2022 (USD Million)
FIG. 8 Global Biopharmaceutical Companies MicroRNA Market, 2020-2022 (USD Million)
FIG. 9 Global Diagnostic Centers MicroRNA Market, 2020-2022 (USD Million)
FIG. 10 Global MicroRNA Market Share, by Region, 2022 & 2030
FIG. 11 North America MicroRNA Market, 2020-2022
FIG. 12 U.S. MicroRNA Market, 2020-2022
FIG. 13 Canada MicroRNA Market, 2020-2022
FIG. 14 Europe MicroRNA Market, 2020-2022
FIG. 15 Germany MicroRNA Market, 2020-2022
FIG. 16 France MicroRNA Market, 2020-2022
FIG. 17 U.K. MicroRNA Market, 2020-2022
FIG. 18 Italy MicroRNA Market, 2020-2022
FIG. 19 Spain MicroRNA Market, 2020-2022
FIG. 20 Rest of Europe MicroRNA Market, 2020-2022
FIG. 21 Asia Pacific MicroRNA Market, 2020-2022
FIG. 22 China MicroRNA Market, 2020-2022
FIG. 23 Japan MicroRNA Market, 2020-2022
FIG. 24 India MicroRNA Market, 2020-2022
FIG. 25 South  Korea MicroRNA Market, 2020-2022
FIG. 26 South-East Asia MicroRNA Market, 2020-2022
FIG. 27 Rest of Asia Pacific MicroRNA Market, 2020-2022
FIG. 28 Latin America MicroRNA Market, 2020-2022
FIG. 29 Brazil MicroRNA Market, 2020-2022
FIG. 30 Mexico MicroRNA Market, 2020-2022
FIG. 31 Rest of Latin America MicroRNA Market, 2020-2022
FIG. 32 The Middle-East and Africa MicroRNA Market, 2020-2022
FIG. 33 GCC Countries MicroRNA Market, 2020-2022
FIG. 34 South Africa MicroRNA Market, 2020-2022
FIG. 35 Rest of Middle-East Africa MicroRNA Market, 2020-2022
FIG. 36 Competitor Market Share – Revenue
FIG. 37 Affymetrix Revenue and Growth Rate
FIG. 38 Affymetrix Market Share
FIG. 39 Alnylam Pharmaceuticals Inc. Revenue and Growth Rate
FIG. 40 Alnylam Pharmaceuticals Inc. Market Share
FIG. 41 AstraZeneca Pharmaceuticals LP Revenue and Growth Rate
FIG. 42 AstraZeneca Pharmaceuticals LP Market Share
FIG. 43 Santaris Pharma Revenue and Growth Rate
FIG. 44 Santaris Pharma Market Share
FIG. 45 Biogen Idec Inc. Revenue and Growth Rate
FIG. 46 Biogen Idec Inc. Market Share
FIG. 47 Exiqon Revenue and Growth Rate
FIG. 48 Exiqon Market Share
FIG. 49 Pfizer Inc. Revenue and Growth Rate
FIG. 50 Pfizer Inc. Market Share
FIG. 51 CBC Biomarker Center GmbH Revenue and Growth Rate
FIG. 52 CBC Biomarker Center GmbH Market Share
FIG. 53 Eli Lilly and Co. Revenue and Growth Rate
FIG. 54 Eli Lilly and Co. Market Share
FIG. 55 F. Hoffman-La Roche Revenue and Growth Rate
FIG. 56 F. Hoffman-La Roche Market Share
FIG. 57 GlaxoSmithKline Revenue and Growth Rate
FIG. 58 GlaxoSmithKline Market Share
FIG. 59 Novartis AG and Merck & Co. Revenue and Growth Rate
FIG. 60 Novartis AG and Merck & Co. Market Share
FIG. 61 Market Dynamics
FIG. 62 Global MicroRNA – Value Chain Analysis
FIG. 63 Technology Roadmap and Timeline
FIG. 64 Market Attractiveness Analysis – By Application
FIG. 65 Market Attractiveness Analysis – By End Use
FIG. 66 Market Attractiveness Analysis – By Region
FIG. 67 Market Channel
FIG. 68 Marketing Channel Development Trend
FIG. 69 Growth in World Gross Product, 2008-2018

List of Tables

TABLE 1 Global MicroRNA Market, 2022 & 2030 (USD Million)
TABLE 2 Global MicroRNA market, by Application, 2020-2022 (USD Million)
TABLE 3 Global MicroRNA market, by End Use, 2020-2022 (USD Million)
TABLE 4 Global MicroRNA market, by Region, 2020-2022 (USD Million)
TABLE 5 North America MicroRNA Market, by Application, 2020-2022 (USD Million)
TABLE 6 North America MicroRNA Market, by End Use, 2020-2022 (USD Million)
TABLE 7 Europe MicroRNA Market, by Application, 2020-2022 (USD Million)
TABLE 8 Europe MicroRNA Market, by End Use, 2020-2022 (USD Million)
TABLE 9 Asia Pacific MicroRNA Market, by Application, 2020-2022 (USD Million)
TABLE 10 Asia Pacific MicroRNA Market, by End Use, 2020-2022 (USD Million)
TABLE 11 Latin America MicroRNA Market, by Application, 2020-2022 (USD Million)
TABLE 12 Latin America MicroRNA Market, by End Use, 2020-2022 (USD Million)
TABLE 13 The Middle-East and Africa MicroRNA Market, by Application, 2020-2022 (USD Million)
TABLE 14 The Middle-East and Africa MicroRNA Market, by End Use, 2020-2022 (USD Million)
TABLE 15 Global MicroRNA Market - Company Revenue Analysis 2020-2030 (USD Million)
TABLE 16 Global MicroRNA Market - Company Revenue Share Analysis 2020-2030(%)
TABLE 17 Acquisitions and Mergers
TABLE 18 New Product/Service Launch
TABLE 19 Research & Development Activities
TABLE 20 Market Drivers
TABLE 21 Market Restraints
TABLE 22 Market Opportunities

Industry Major Market Players

Affymetrix
Alnylam Pharmaceuticals Inc.
AstraZeneca Pharmaceuticals LP
Santaris Pharma
Biogen Idec Inc.
Exiqon
Pfizer Inc.
CBC Biomarker Center GmbH
Eli Lilly and Co.
F. Hoffman-La Roche
GlaxoSmithKline
Novartis AG and Merck & Co.